KR20230173287A - A cosmetic composition comprising rucinol and natural extracts for skin-whitening - Google Patents
A cosmetic composition comprising rucinol and natural extracts for skin-whitening Download PDFInfo
- Publication number
- KR20230173287A KR20230173287A KR1020220073862A KR20220073862A KR20230173287A KR 20230173287 A KR20230173287 A KR 20230173287A KR 1020220073862 A KR1020220073862 A KR 1020220073862A KR 20220073862 A KR20220073862 A KR 20220073862A KR 20230173287 A KR20230173287 A KR 20230173287A
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- cosmetic composition
- extract
- comparative example
- rucinol
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 239000002537 cosmetic Substances 0.000 title claims abstract description 55
- 239000000284 extract Substances 0.000 title claims abstract description 42
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 230000002087 whitening effect Effects 0.000 claims abstract description 18
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims abstract description 5
- 241000220479 Acacia Species 0.000 claims abstract 3
- 239000006071 cream Substances 0.000 claims description 22
- 230000037303 wrinkles Effects 0.000 claims description 20
- 239000006210 lotion Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- -1 mask pack Substances 0.000 claims description 10
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 9
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 239000007921 spray Substances 0.000 claims description 8
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 206010051246 Photodermatosis Diseases 0.000 claims description 5
- 239000000686 essence Substances 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 4
- 230000008845 photoaging Effects 0.000 claims description 4
- 239000003708 ampul Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 description 83
- 210000003491 skin Anatomy 0.000 description 53
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 13
- 230000006872 improvement Effects 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 8
- 230000002195 synergetic effect Effects 0.000 description 8
- 229910002091 carbon monoxide Inorganic materials 0.000 description 7
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000009759 skin aging Effects 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 210000002752 melanocyte Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000007760 free radical scavenging Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000218996 Passiflora Species 0.000 description 2
- 244000288157 Passiflora edulis Species 0.000 description 2
- 235000000370 Passiflora edulis Nutrition 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001521901 Tribulus lanuginosus Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 229960001701 chloroform Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 241000218642 Abies Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000143476 Bidens Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001255990 Clematis terniflora var. mandshurica Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 101710200814 Melanotropin alpha Proteins 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001120 cytoprotective effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000006318 protein oxidation Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/591—Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596
Abstract
본 발명은 피부 미백용 화장료 조성물에 관한 것으로, 루시놀(Rucinol) 및 가막사리 추출물을 유효성분으로 포함하는 화장료 조성물을 제공한다.The present invention relates to a cosmetic composition for skin whitening, and provides a cosmetic composition containing rucinol and acacia extract as active ingredients.
Description
본 발명은 피부 자극이 적고, 피부 미백 효과가 현저히 개선된 다기능성 화장료 조성물에 관한 것이다.The present invention relates to a multifunctional cosmetic composition with less skin irritation and significantly improved skin whitening effect.
피부는 외부환경과 접촉하여 자극에 대한 신체를 보호하는 가장 기초적인 방어기관이며, 외적인 아름다움을 표현하는 중요한 기관이다.The skin is the most basic defense organ that protects the body from irritation in contact with the external environment, and is an important organ that expresses external beauty.
외적인 아름다움이 젊음과 건강을 상징하는 판단의 기준일 뿐 아니라 자신감을 표출하여 업무능력에 영향을 주는 경쟁력으로 자리잡고 있기 때문에, 현대사회에서 피부를 관리하는 경향이 증가하고 있다.Because external beauty is not only a criterion for judgment, symbolizing youth and health, but also a competitive advantage that expresses confidence and affects work ability, the tendency to take care of one's skin is increasing in modern society.
산업이 발달함에 따라 환경 오염이 심각해지고, 피부의 노화 방지, 미백 등에 관한 관심이 고조되고 있다. As the industry develops, environmental pollution becomes more serious, and interest in anti-aging and whitening of the skin is increasing.
특히, 사람의 피부는 끊임없이 변화를 겪게 되는데, 가장 대표적인 변화가 노화에 의한 피부 기능 저하 및 시각적 아름다움의 감소이다. In particular, human skin constantly undergoes changes, the most representative changes being the decline in skin function and visual beauty due to aging.
피부 노화의 결과 나타나는 최종적인 피부 외관에서의 현상은 주름의 형성, 피부 탄력 저하, 노인성 반점 형성 등이 있으며, 주름의 형성이 가장 대표적인 현상으로 손꼽힌다.Final skin appearance phenomena that occur as a result of skin aging include the formation of wrinkles, decreased skin elasticity, and formation of senile spots, with the formation of wrinkles being considered the most representative phenomenon.
피부의 주요 구성물질인 지질, 단백질, 다당류 및 핵산 등은 산화되어 피부 세포 및 조직이 파괴될 수 있으며, 결국 피부가 노화될 수 있다.Lipids, proteins, polysaccharides, and nucleic acids, which are the main components of skin, can be oxidized, destroying skin cells and tissues, and ultimately causing skin aging.
특히, 단백질의 산화에 의해 피부의 결합조직인 콜라겐, 히알루론산, 엘라스틴, 프로테오글라이칸, 피브로넥틴 등이 절단되고 과다 염증반응이 나타날 수 있으며, 더욱 심화되는 경우 DNA 변이에 의한 돌연변이, 면역기능의 저하, 암의 유발이 촉진될 수 있다.In particular, due to protein oxidation, the connective tissue of the skin, such as collagen, hyaluronic acid, elastin, proteoglycan, and fibronectin, may be cut and an excessive inflammatory response may occur. In further cases, mutations due to DNA mutation and a decrease in immune function may occur. , the cause of cancer may be promoted.
따라서, 신체의 대사 과정 중 발생하는 활성산소종이나 자외선 조사, 염증반응에 의해 매개 되는 활성산소종을 소거하여 세포막을 보호하고, 활발한 신진대사를 통해 손상 받은 세포를 재생시켜 피부 건강을 회복시키는 것이 바람직하다.Therefore, it is important to protect cell membranes by scavenging reactive oxygen species generated during the body's metabolic process, ultraviolet irradiation, and inflammatory reactions, and to restore skin health by regenerating damaged cells through active metabolism. desirable.
한편, 멜라닌(Melanin)은 피부, 모발 등에 존재하는 흑색 또는 갈색 색소를 말한다. 멜라닌은 피부에 존재하며, 자외선을 차단하여 피부를 보호하고, 피부의 체온을 유지시켜주는 기능을 한다.Meanwhile, melanin refers to a black or brown pigment present in skin, hair, etc. Melanin exists in the skin and has the function of protecting the skin by blocking ultraviolet rays and maintaining the skin's body temperature.
멜라닌은 색소 세포 내에 존재하는 타이로시네이즈의 작용에 의해 타이로신으로부터 도파(dopa), 도파퀴논(dopaquinone)으로 변환되어 도파크롬(dopachrome) 등을 거쳐 생성된다. Melanin is produced by converting tyrosine into dopa and dopaquinone through the action of tyrosinase present in pigment cells and passing through dopachrome.
멜라닌은 자외선 등 피부 유해 요소로부터 신체를 보호하고 체내 호르몬 분비를 조절하는 역할을 한다.Melanin protects the body from harmful skin elements such as ultraviolet rays and regulates hormone secretion in the body.
그러나, 멜라닌은 과잉 생산되어 기미, 주근깨의 형성 및 피부노화를 촉진시킬 수 있으며, 피부암의 유발에 관여할 수 있으므로, 멜라닌의 과잉생산을 억제하기 위한 연구개발이 활발하게 이루어지고 있다.However, melanin is overproduced and can promote the formation of spots and freckles and skin aging, and can be involved in causing skin cancer, so research and development is being actively conducted to suppress the overproduction of melanin.
최근 화장품 업계는 여러 화학물질 등에 의한 피부 자극을 줄이기 위해 천연물을 사용한 다수의 제품을 개발하고 있다. Recently, the cosmetics industry has been developing a number of products using natural products to reduce skin irritation caused by various chemicals.
천연 재료는 피부에 부작용이 적을 뿐 아니라, 최근 천연 재료를 이용한 화장품에 대한 소비자들의 호응이 높아짐에 따라 화장품 원료로서 개발가치가 점차 증가하고 있다. Not only do natural ingredients have fewer side effects on the skin, but their development value as cosmetic raw materials is gradually increasing as consumers' response to cosmetics using natural ingredients has recently increased.
이와 같이 본 발명자들은 생체 안전성 및 피부 개선 효과가 우수한 천연물 유래 화장품 제품의 개발 필요성이 꾸준히 대두되고 있는 상황에서, 천연 추출물을 이용한 우수한 기능성의 화장료 조성물을 개발하고자 하였다.As such, the present inventors attempted to develop a cosmetic composition with excellent functionality using natural extracts in a situation where the need for developing cosmetic products derived from natural products with excellent biosafety and skin improvement effects is constantly emerging.
(특허문헌 1) 대한민국등록특허 제10-2014842호(Patent Document 1) Republic of Korea Patent No. 10-2014842
(특허문헌 2) 대한민국등록특허 제10-2336538호(Patent Document 2) Republic of Korea Patent No. 10-2336538
본 발명은 전술한 문제점을 해결하기 위한 것으로, 본 발명의 목적은 피부 안전성이 검증된 원료를 통해 우수한 시너지 활성을 규명하고, 이를 통해 기능성과 함께 생체 안전성이 우수한 화장료 조성물을 제공하는 것이다.The present invention is intended to solve the above-mentioned problems, and the purpose of the present invention is to identify excellent synergistic activity through raw materials with proven skin safety, and thereby provide a cosmetic composition with excellent functionality and biosafety.
본 발명의 일 측면에 따르면, 루시놀(Rucinol) 및 가막사리 추출물을 유효성분으로 포함하는 피부 미백용 화장료 조성물이 제공된다.According to one aspect of the present invention, there is provided a cosmetic composition for skin whitening containing rucinol and Camagsari extract as active ingredients.
일 실시예에 있어서, 상기 화장료 조성물은 으아리 추출물을 더 포함할 수 있다.In one embodiment, the cosmetic composition may further include euri extract.
일 실시예에 있어서, 상기 화장료 조성물은 메밀꽃 추출물을 더 포함할 수 있다.In one embodiment, the cosmetic composition may further include buckwheat flower extract.
일 실시예에 있어서, 상기 화장료 조성물은 백향과 추출물 및 질려자 추출물 중 하나 이상을 더 포함할 수 있다.In one embodiment, the cosmetic composition may further include one or more of Baekhyangaceae extract and Jilryeoja extract.
일 실시예에 있어서, 상기 화장료 조성물은 항산화 용도를 더 포함할 수 있다.In one embodiment, the cosmetic composition may further include antioxidant properties.
일 실시예에 있어서, 상기 화장료 조성물은 주름 개선 또는 광노화 방지 용도를 더 포함할 수 있다.In one embodiment, the cosmetic composition may further include a use for improving wrinkles or preventing photoaging.
일 실시예에 있어서, 상기 화장료 조성물은 유연화장수, 영양화장수, 수분크림, 영양크림, 마사지크림, 영양로션, 에센스, 앰플, 젤, 아이크림, 오일, 파운데이션, 클렌징크림, 클렌징폼, 클렌징워터, 마스크팩, 스프레이 및 파우더로 이루어진 군에서 선택된 하나 이상으로 제형화될 수 있다.In one embodiment, the cosmetic composition includes softening lotion, nourishing lotion, moisturizing cream, nourishing cream, massage cream, nourishing lotion, essence, ampoule, gel, eye cream, oil, foundation, cleansing cream, cleansing foam, cleansing water, It may be formulated with one or more selected from the group consisting of mask pack, spray, and powder.
본 발명의 다른 측면에 따르면, 루시놀(Rucinol) 및 가막사리 추출물을 유효성분으로 포함하는 피부 미백용 외용제 조성물이 제공된다.According to another aspect of the present invention, there is provided an external composition for skin whitening containing rucinol and Camagsari extract as active ingredients.
본 발명에 따르면, 상기 화장료 조성물 조성물은 천연 성분 대비 피부 자극을 유발할 수 있는 화학 물질의 함량을 최소화할 수 있다.According to the present invention, the cosmetic composition composition can minimize the content of chemical substances that can cause skin irritation compared to natural ingredients.
상기 화장료 조성물은 기존에 알려진 화합물과 천연 성분의 시너지 활성을 통해 피부 미백 효과가 현저히 증진될 수 있다.The skin whitening effect of the cosmetic composition can be significantly improved through the synergistic activity of previously known compounds and natural ingredients.
본 발명의 효과는 상기한 효과로 한정되는 것은 아니며, 본 발명의 상세한 설명 또는 특허청구범위에 기재된 발명의 구성으로부터 추론 가능한 모든 효과를 포함하는 것으로 이해되어야 한다.The effects of the present invention are not limited to the effects described above, and should be understood to include all effects that can be inferred from the configuration of the invention described in the detailed description or claims of the present invention.
본 명세서에서 사용되는 용어는 본 발명에서의 기능을 고려하면서 가능한 현재 널리 사용되는 일반적인 용어들을 선택하였으나, 이는 당 분야에 종사하는 기술자의 의도 또는 판례, 새로운 기술의 출현 등에 따라 달라질 수 있다. 또한, 특정한 경우는 출원인이 임의로 선정한 용어도 있으며, 이 경우 해당되는 발명의 설명 부분에서 상세히 그 의미를 기재할 것이다. 따라서 본 발명에서 사용되는 용어는 단순한 용어의 명칭이 아닌, 그 용어가 가지는 의미와 본 발명의 전반에 걸친 내용을 토대로 정의되어야 한다.The terms used in this specification are general terms that are currently widely used as much as possible while considering the function in the present invention, but this may vary depending on the intention or precedent of a person skilled in the art, the emergence of new technology, etc. In addition, in certain cases, there are terms arbitrarily selected by the applicant, and in this case, the meaning will be described in detail in the description of the relevant invention. Therefore, the terms used in the present invention should be defined based on the meaning of the term and the overall content of the present invention, rather than simply the name of the term.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by a person of ordinary skill in the technical field to which the present invention pertains. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related technology, and unless clearly defined in the present application, should not be interpreted in an ideal or excessively formal sense. No.
수치 범위는 상기 범위에 정의된 수치를 포함한다. 본 명세서에 걸쳐 주어진 모든 최대의 수치 제한은 낮은 수치 제한이 명확히 쓰여져 있는 것처럼 모든 더 낮은 수치 제한을 포함한다. 본 명세서에 걸쳐 주어진 모든 최소의 수치 제한은 더 높은 수치 제한이 명확히 쓰여져 있는 것처럼 모든 더 높은 수치 제한을 포함한다. 본 명세서에 걸쳐 주어진 모든 수치 제한은 더 좁은 수치 제한이 명확히 쓰여져 있는 것처럼, 더 넓은 수치 범위 내의 더 좋은 모든 수치 범위를 포함할 것이다.The numerical range includes the values defined in the range above. Every maximum numerical limit given throughout this specification includes all lower numerical limits as if the lower numerical limit were explicitly written out. Every minimum numerical limit given throughout this specification includes every higher numerical limit as if such higher numerical limit was clearly written. All numerical limits given throughout this specification will include all better numerical ranges within the broader numerical range, as if the narrower numerical limits were clearly written.
이하, 본 발명의 실시예를 상세히 기술하나, 하기 실시예에 의해 본 발명이 한정되지 아니함은 자명하다.Hereinafter, examples of the present invention will be described in detail, but it is obvious that the present invention is not limited to the following examples.
본 발명의 일 측면은 루시놀(Rucinol) 및 가막사리 추출물을 유효성분으로 포함하는 피부 미백용 화장료 조성물을 제공하고, 본 발명의 다른 측면은 루시놀(Rucinol) 및 가막사리 추출물을 유효성분으로 포함하는 피부 미백용 외용제 조성물을 제공한다.One aspect of the present invention provides a cosmetic composition for skin whitening containing rucinol and a cauliflower extract as active ingredients, and another aspect of the present invention provides a cosmetic composition for skin whitening containing rucinol and a cauliflower extract as active ingredients. Provided is a whitening external composition.
상기 화장료 조성물은 루시놀과 함께 다양한 복합 성분의 시너지 활성을 통해 피부 미백을 포함하는 우수한 피부 기능성을 구현할 수 있다.The cosmetic composition can realize excellent skin functionality, including skin whitening, through the synergistic activity of various complex ingredients together with rucinol.
상기 루시놀(Rucinol, 4-n-butyl-resorcinol)은 하기 화학식 1의 화합물로 전나무에 포함되어 있는 물질과 구조적으로 유사하며, 자외선 등에 의한 피부 색소 침착의 원인이 되는 효소인 티로시나제 저해효과가 우수하다.Rucinol (4-n-butyl-resorcinol) is a compound of the following formula (1) and is structurally similar to substances contained in fir trees, and has an excellent inhibitory effect on tyrosinase, an enzyme that causes skin pigmentation due to ultraviolet rays, etc. .
[화학식 1][Formula 1]
상기 가막사리(Bidens tripartite)는 쌍떡잎식물 초롱꽃목 국화과의 한해살이풀로, 밭둑이나 물가에서 자라며, 휴경한 논이나 산간지의 논에서 발생이 많아 피해를 주기도 하는 식물이다. 상기 가막사리의 갈고리 같은 가시털은 다른 물체에 잘 달라붙고, 어린잎은 식용으로 사용한다.The Bidens tripartite is an annual herb of the dicotyledonous plant Campanula Asteraceae. It grows on field banks or near water, and is a plant that often causes damage in fallow rice fields or mountainous rice fields. The hook-like thorn hairs of the above-mentioned lily stick well to other objects, and the young leaves are used for food.
상기 화장료 조성물은 으아리 추출물을 더 포함할 수 있다.The cosmetic composition may further include euri extract.
상기 으아리(Clematis mandshurica)는 우리나라 각처의 산과 들에서 자라는 낙엽 덩굴식물로서 잎은 마주나고 작은 잎은 달걀 모양인데 끝이 점차 좁아지고 밑은 둥글거나 쐐기 모양이다. 상기 으아리의 열매는 9월경에 익고, 관상용으로 쓰이며, 어린잎은 식용, 뿌리는 약용으로 쓰인다.The above-mentioned Clematis mandshurica is a deciduous vine that grows in the mountains and fields of various parts of Korea. The leaves are opposite each other and the small leaves are egg-shaped, but the end gradually narrows and the bottom is round or wedge-shaped. The fruits of the above ripen around September and are used for ornamental purposes, the young leaves are edible, and the roots are used for medicinal purposes.
상기 화장료 조성물은 메밀꽃 추출물을 더 포함할 수 있다.The cosmetic composition may further include buckwheat flower extract.
상기 메밀(Fagopyrum esculentum)은 마디풀과에 속하는 일년초로서 분류학상 곡류와 구별되지만 곡류와 유사한 특성을 가진 유사 곡물이며, 탄수화물, 단백질, 라이신, 아르기닌, 메티오닌 등의 필수 아미노산, 불포화 지방산 및 각종 무기물과 비타민을 함유하고 있다. The buckwheat ( Fagopyrum esculentum ) is an annual plant belonging to the family Gadulaceae and is taxonomically distinct from grains, but is a similar grain with similar characteristics to grains, and contains carbohydrates, proteins, essential amino acids such as lysine, arginine, and methionine, unsaturated fatty acids, and various minerals and vitamins. It contains.
상기 메밀 단백질은 라이신이 약 6.1%(w/w), 메티오닌은 약 2.5%(w/w)로 다른 곡류에 비해서 라이신의 함량이 높은 것이 특징이다.The buckwheat protein is characterized by a high lysine content compared to other grains, with lysine at about 6.1% (w/w) and methionine at about 2.5% (w/w).
상기 메밀꽃은 8 내지 9월에 개화하며, 메밀꽃에는 특히 꿀이 많기 때문에 꿀벌의 좋은 밀원 식물이 되기도 한다.The buckwheat flowers bloom in August to September, and because they contain a lot of honey, they are a good source of honey for bees.
상기 화장료 조성물은 백향과 추출물 및 질려자 추출물 중 하나 이상을 더 포함할 수 있다.The cosmetic composition may further include one or more of Baekhyangaceae extract and Jilryeoberry extract.
상기 백향과는 시계초(Passiflora edulis)라고도 불리며, 아열대와 열대지역에서 재배되고 있는 다년생 상록덩굴 식물로 시계꽃과 시계꽃속에 속하고 전 세계적으로 500여 종이 분포한다. 상기 백향과의 식용 부위는 열매로 무게는 40 내지 70 g 정도이고 풍미와 향기가 좋아 생식하거나 음료수, 가공품, 향수 등을 만들 때 사용된다.The above-mentioned Passiflora edulis is also called Passiflora edulis , and is a perennial evergreen vine plant cultivated in subtropical and tropical regions. It belongs to the genus Passiflora and Passiflora, and about 500 species are distributed around the world. The edible part of the Baekhyang family is a fruit that weighs about 40 to 70 g and has a good flavor and aroma, so it is used raw or in making beverages, processed products, perfume, etc.
상기 백향과는 종자, 과육, 과피, 또는 이들의 임의의 조합을 사용할 수 있고, 바람직하게는 종자, 과육, 또는 이들의 조합을 사용할 수 있으나 이에 한정되는 것은 아니다.The Baekhyanggwa may be made of seeds, pulp, skin, or any combination thereof. Preferably, seeds, pulp, or a combination thereof may be used, but is not limited thereto.
상기 질려자(Tribulus terrestris)는 백질려라고도 불리며, 질려과에 속한 1년생 또는 다년생 초본인 납가새의 성숙한 열매를 건조한 것이다. The Tribulus terrestris is also called Baekjiryeo, and is made by drying the mature fruits of Nappasae, an annual or perennial herb belonging to the Tribulus terrestris family.
상기 질려자는 일정한 강압 및 이뇨 작용 효과가 있는 것으로 알려지며, 일년생 초본인 남가새의 과실은 안과 질환에 사용된다.The above-mentioned plant is known to have certain coercive and diuretic effects, and the fruit of Namgasae, an annual herb, is used for eye diseases.
한편, 상기 추출물은 당업계에 공지된 추출법에 의하여 파쇄된 천연 원료를 추출 용매에 침지 및 가열시켜 제조할 수 있다. Meanwhile, the extract can be prepared by immersing and heating crushed natural raw materials in an extraction solvent using an extraction method known in the art.
상기 추출 용매는 물, 탄소수 1 내지 4개의 무수 또는 함수 저급 알코올, 아세톤, 석유에테르, 에틸아세테이트, 부틸아세테이트, 트리클로로메탄, 디클로로메탄, 클로로포름, 헥산 및 1,3-부틸렌글리콜로 구성된 군으로부터 선택되는 하나 이상의 용매일 수 있고, 바람직하게는 65 내지 75% 농도(v/v)의 에탄올일 수 있으며, 2 이상의 서로 다른 용매를 혼합하여 사용하거나 순차적으로 사용할 수 있으나, 이에 한정되지 않는다.The extraction solvent is selected from the group consisting of water, anhydrous or hydrous lower alcohols having 1 to 4 carbon atoms, acetone, petroleum ether, ethyl acetate, butyl acetate, trichloromethane, dichloromethane, chloroform, hexane, and 1,3-butylene glycol. It may be one or more solvents selected, preferably ethanol at a concentration (v/v) of 65 to 75%, and two or more different solvents may be mixed or used sequentially, but are not limited thereto.
상기 원료에 포함된 유효성분은 용매의 극성에 따라 추출 비율이 상이해질 수 있으며, 상기 에탄올은 천연 원료의 생리 활성 물질의 추출에 있어서 선택성이 뛰어나므로 상기 에탄올 추출에 의해 최적의 피부 개선 효과가 구현될 수 있다. The extraction ratio of the active ingredients contained in the raw materials may vary depending on the polarity of the solvent, and since ethanol has excellent selectivity in extracting biologically active substances from natural raw materials, the optimal skin improvement effect is realized by the ethanol extraction. It can be.
특히, 물과 에탄올은 극성이 상이하여, 각 극성에 따라 추출되는 유효성분이 서로 차이가 날 수 있으므로 최적의 피부 개선 효과가 구현될 수 있도록 상기 에탄올의 농도를 적절히 제어할 수 있다.In particular, water and ethanol have different polarities, so the active ingredients extracted according to each polarity may differ from each other, so the concentration of the ethanol can be appropriately controlled to achieve the optimal skin improvement effect.
상기 화장료 조성물은 항산화 용도를 더 포함할 수 있다.The cosmetic composition may further include antioxidant properties.
상기 “항산화(anti-oxidant)”는 산화를 억제하는 작용을 의미하는 것으로, 인체는 산화 촉진 물질과 산화 억제 물질이 균형을 이루고 있으나, 여러 가지 요인들로 인하여 이러한 균형 상태를 잃고 산화를 촉진하는 방향으로 기울게 되면, 생체 내에 산화적 스트레스(oxidative stress)가 유발되어 세포손상 및 병리적 질환을 유발할 수 있다.The term “anti-oxidant” refers to the action of suppressing oxidation. The human body maintains a balance of pro-oxidation and inhibitory substances, but due to various factors, this balance is lost and oxidation is promoted. When tilted in one direction, oxidative stress is induced in the body, which can cause cell damage and pathological diseases.
상기 산화적 스트레스의 직접적 원인이 되는 활성 산소종(reactive oxygen species, ROS)은 화학적으로 불안정하고 반응성이 높아 DNA, 단백질, 지질 및 탄수화물과 같은 여러 생체물질과 쉽게 반응할 수 있으며, 생체 내 고분자들을 공격하여 세포와 조직에 비가역적인 손상을 일으키거나 돌연변이, 세포독성 및 암 등을 초래하게 되고, 노화의 직접적인 원인이 되기도 한다. Reactive oxygen species (ROS), which are the direct cause of the oxidative stress, are chemically unstable and highly reactive, so they can easily react with various biological materials such as DNA, proteins, lipids, and carbohydrates, and can destroy macromolecules in vivo. It attacks cells and tissues, causing irreversible damage or causing mutations, cytotoxicity, and cancer, and can also be a direct cause of aging.
상기 활성 산소종을 제거하거나 감소시킴으로써 항산화 효과를 얻어 노화를 방지하고 건강을 유지할 수 있다.By removing or reducing the reactive oxygen species, an antioxidant effect can be obtained to prevent aging and maintain health.
상기 화장료 조성물은 주름 개선 또는 광노화 방지 용도를 더 포함할 수 있다.The cosmetic composition may further include uses for improving wrinkles or preventing photoaging.
상기 “주름개선”은 엘라스틴으로 구성된 탄력섬유가 콜라겐과 함께 존재하며, 상기 엘라스틴과 콜라겐이 충분히 존재하는 상태에서 피부 탄력이 유지 또는 향상되는 현상을 의미한다. 또한 상기 "주름개선"은 피부에 주름이 생성되는 것을 억제 또는 저해하거나, 이미 생성된 주름이 완화되는 현상을 의미한다.The “wrinkle improvement” refers to the phenomenon in which elastic fibers composed of elastin exist together with collagen, and skin elasticity is maintained or improved when the elastin and collagen are sufficiently present. In addition, the term “wrinkle improvement” refers to the phenomenon of suppressing or inhibiting the formation of wrinkles on the skin or relieving already formed wrinkles.
상기 “광노화 방지”는 자외선 차단 또는 UVB에 의해 유도되는 피부 노화 방지용일 수 있다. The “anti-photoaging” may be for blocking ultraviolet rays or preventing skin aging induced by UVB.
상기 “광노화(Photoaging)”는 외부 환경적인 요인인 자외선에 의해 유발되는 노화 현상이다. 상기 자외선은 단백질 분해효소를 활성화하고 기질단백질의 사슬절단 및 비정상적인 교차결합 등을 야기하여 생체 구성 성분들의 손상을 결과하고 상기 메커니즘의 반복은 외관상 확연한 피부노화를 초래할 수 있다. The “photoaging” is an aging phenomenon caused by ultraviolet rays, an external environmental factor. The ultraviolet rays activate proteolytic enzymes and cause chain breaks and abnormal cross-linking of matrix proteins, resulting in damage to biological components, and repetition of the above mechanism can result in apparent skin aging.
상기 화장료 조성물은 외부환경과는 무관하게 유전적 요소에 의해 발생하는 내인성 노화와 달리 자외선에 의해 유도되는 피부 노화를 효과적으로 개선할 수 있다.The cosmetic composition can effectively improve skin aging induced by ultraviolet rays, unlike intrinsic aging caused by genetic factors regardless of the external environment.
상기 화장료 조성물은 유연화장수, 영양화장수, 수분크림, 영양크림, 마사지크림, 영양로션, 에센스, 앰플, 젤, 아이크림, 오일, 파운데이션, 클렌징크림, 클렌징폼, 클렌징워터, 마스크팩, 스프레이 및 파우더로 이루어진 군에서 선택된 하나 이상으로 제형화될 수 있으나 이에 제한되는 것은 아니다.The cosmetic composition includes softening lotion, nourishing lotion, moisturizing cream, nourishing cream, massage cream, nourishing lotion, essence, ampoule, gel, eye cream, oil, foundation, cleansing cream, cleansing foam, cleansing water, mask pack, spray, and powder. It may be formulated with one or more selected from the group consisting of, but is not limited thereto.
또한, 상기 피부 외용제 조성물은 크림, 젤, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 및 카타플라스마제로 이루어진 군에서 선택된 하나 이상으로 제형화될 수 있으나, 이에 제한되는 것은 아니다.In addition, the composition for external skin application may be formulated with one or more selected from the group consisting of creams, gels, patches, sprays, ointments, warning agents, lotions, liniment agents, pasta agents, and cataplasma agents, but is limited thereto. no.
상기 화장료 조성물은 통상의 방법에 의해 제형화될 수 있다. 상기 화장료 조성물의 제형화에 있어서, 예컨대, International cosmetic ingredient dictionary, 6th ed(The cosmetic, Toiletry and Fragrance Association, Inc., Washington, 1995)에 개시되어 있는 내용을 참조할 수 있고, 상기 피부 외용제의 제형화에 있어서 Remington's Pharmaceutical Science, Mack Publishing Company, Easton PA에 개시되어 있는 내용을 참조할 수 있다.The cosmetic composition can be formulated by conventional methods. In formulating the cosmetic composition, for example, the content disclosed in the International cosmetic ingredient dictionary, 6th ed (The cosmetic, Toiletry and Fragrance Association, Inc., Washington, 1995) may be referred to, and the formulation of the skin external preparation In this regard, reference may be made to the content disclosed in Remington's Pharmaceutical Science, Mack Publishing Company, Easton PA.
구체적으로, 상기 화장료 조성물은 일반적인 유화 제형 및 가용화 제형으로 제조할 수 있다. 예컨대, 유연 화장수 또는 영양 화장수 등의 화장수; 훼이셜 로션, 바디로션 등의 유액; 영양 크림, 수분 크림, 아이 크림 등의 크림; 에센스; 화장연고; 스프레이; 젤; 팩; 선 스크린; 메이크업 베이스; 액체 타입, 고체 타입 또는 스프레이 타입 등의 파운데이션; 파우더; 클렌징 크림, 클렌징 로션, 클렌징 오일 등의 메이크업 제거제; 또는 클렌징 폼, 비누, 바디워시 등의 세정제로 제형화될 수 있으나 이에 한정되는 것은 아니다. Specifically, the cosmetic composition can be prepared in a general emulsified formulation and solubilized formulation. For example, lotion such as softening lotion or nourishing lotion; Emulsions such as facial lotion and body lotion; Creams such as nutritional cream, moisture cream, eye cream, etc.; essence; cosmetic ointment; spray; gel; pack; sunscreen; makeup base; Foundation, such as liquid type, solid type, or spray type; powder; Make-up removers such as cleansing creams, cleansing lotions, and cleansing oils; Alternatively, it may be formulated as a cleansing agent such as cleansing foam, soap, or body wash, but is not limited to this.
상기 화장료 조성물 및 피부 외용제 조성물은 각각의 제형에 있어서 상기 필수성분 외에 제형의 종류 또는 사용 목적 등에 따라 본 발명에 따른 목적을 저해하지 않는 범위 내에서 다른 성분들이 적절히 배합될 수 있다.In addition to the above essential ingredients, other ingredients may be appropriately mixed in the cosmetic composition and skin external composition in each formulation, depending on the type of formulation or purpose of use, within the range that does not impair the purpose of the present invention.
상기 화장료 조성물 및 피부 외용제 조성물은 통상적으로 허용 가능한 담체를 포함할 수 있으며, 예컨대 유분, 물, 계면활성제, 보습제, 저급 알코올, 증점제, 킬레이트제, 색소, 방부제, 향료 등을 적절히 배합할 수 있으나, 이에 한정되는 것은 아니다.The cosmetic composition and external skin preparation composition may contain commonly acceptable carriers, such as oil, water, surfactant, moisturizer, lower alcohol, thickener, chelating agent, colorant, preservative, fragrance, etc., may be appropriately mixed. It is not limited to this.
상기 허용 가능한 담체는 제형에 따라 달리할 수 있다. 예컨대, 연고, 페이스트, 크림 또는 젤로 제형화될 때 담체 성분으로서 동물성 유, 식물성 유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크, 산화아연 또는 이들의 혼합물이 사용될 수 있다.The acceptable carrier may vary depending on the formulation. For example, when formulated into ointments, pastes, creams or gels, animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivatives, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide or these are used as carrier ingredients. Mixtures may be used.
상기 화장료 조성물 및 피부 외용제 조성물은 파우더 또는 스프레이로 제형화될 때, 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록사이드, 칼슘 실케이트, 폴리아미드 파우더 또는 이들의 혼합물이 사용될 수 있고, 스프레이의 경우 클로로플루오로히드로카본, 프로판, 부탄 또는 디메틸 에테르와 같은 추진제를 더 포함할 수 있다.When the cosmetic compositions and external skin compositions are formulated as powders or sprays, lactose, talc, silica, aluminum hydroxide, calcium silcate, polyamide powder, or mixtures thereof may be used as carrier ingredients, and in the case of sprays, It may further include propellants such as chlorofluorohydrocarbon, propane, butane or dimethyl ether.
상기 화장료 조성물 및 피부 외용제 조성물은 용액 또는 유탁액으로 제형화될 때, 담체 성분으로서 용매, 용해화제, 또는 유탁화제가 사용될 수 있고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-브틸글리콜 오일이 사용될 수 있고, 특히, 목화씨 오일, 땅콩 오일, 옥수수 배종 오일, 올리브 오일, 피마자 오일 및 참깨 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 사용될 수 있다. When the cosmetic compositions and compositions for topical skin application are formulated as a solution or emulsion, a solvent, solubilizing agent, or emulsifying agent may be used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, and benzyl benzoate. , propylene glycol, 1,3-butyl glycol oil can be used, in particular cottonseed oil, peanut oil, corn germ oil, olive oil, castor oil and sesame oil, glycerol aliphatic esters, polyethylene glycol or fatty acid esters of sorbitan. can be used
상기 화장료 조성물 및 피부 외용제 조성물은 현탁액으로 제형화될 때, 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리 옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 사용될 수 있다.When the cosmetic composition and external skin composition are formulated as a suspension, the carrier ingredients include water, a liquid diluent such as ethanol or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester. The same suspending agent, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar, or tracant may be used.
상기 화장료 조성물 및 피부 외용제 조성물은 비누로 제형화될 때, 담체 성분으로서 지방산의 알칼리 금속 염, 지방산 헤미에스테르 염, 지방산 단백질 히드롤리제이트, 이세티오네이트, 라놀린 유도체, 지방족 알코올, 식물성 유, 글리세롤, 당 등이 사용될 수 있다.When the cosmetic composition and skin external composition are formulated as soap, the carrier ingredients include alkali metal salts of fatty acids, fatty acid hemiester salts, fatty acid protein hydrolysates, isethionates, lanolin derivatives, fatty alcohols, vegetable oil, and glycerol. , sugar, etc. may be used.
상기 화장료 조성물 및 피부 외용제 조성물은 최종 제품의 품질이나 기능에 따라 업계에서 통상적으로 사용되는 지방 물질, 유기용매, 용해제, 농축제, 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉 쇄제, 킬레이트화제, 보존제, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 추가적으로 함유할 수 있다.The cosmetic composition and skin external composition may contain fatty substances, organic solvents, solubilizers, thickeners, gelling agents, softeners, antioxidants, suspending agents, stabilizers, and foaming agents commonly used in the industry depending on the quality or function of the final product. agent), fragrance, surfactant, water, ionic or non-ionic emulsifier, filler, metal ion sequestering agent, chelating agent, preservative, blocking agent, wetting agent, essential oil, dye, pigment, hydrophilic or lipophilic activator, cosmetics It may additionally contain auxiliaries commonly used in the fields of cosmetology or dermatology, such as any other commonly used ingredients.
다만, 상기 보조제 및 그 혼합 비율은 본 발명에 따른 화장료 조성물의 바람직한 성질에 영향을 미치지 않도록 적절히 선택할 수 있다.However, the auxiliaries and their mixing ratio may be appropriately selected so as not to affect the desirable properties of the cosmetic composition according to the present invention.
이하 실시예를 통해, 본 발명을 더욱 상술하나 하기 실시예에 의해 본 발명이 제한되지 아니함은 자명하다.The present invention will be described in further detail through the following examples, but it is obvious that the present invention is not limited by the following examples.
실시예 및 비교예Examples and Comparative Examples
본 발명의 루시놀 및 천연 복합 성분의 안정성 및 기능성을 검증하고자 하기 표 1 및 2와 같이 시료를 혼합하여 실시예 및 비교예를 설정하였다. In order to verify the stability and functionality of the rucinol and natural composite components of the present invention, samples were mixed as shown in Tables 1 and 2 below, and examples and comparative examples were set.
각 시료는 분발 상태의 제품을 시중에서 구득하여 사용하였다.For each sample, powdered products were obtained from the market and used.
실험예 1 : 피부 안전성 시험Experimental Example 1: Skin safety test
실시예 및 비교예의 시료에 대한 피부 안전성을 검증하기 위해, 섬유아세포(HDF)에 대한 MTT assay 실험을 수행하였다.To verify the skin safety of the samples of Examples and Comparative Examples, MTT assay experiments on fibroblasts (HDF) were performed.
실시예 및 비교예의 시료를 정제수에 50, 100, 200, 400 μg/mL의 농도별로 각각 현탁한 후, 세포 생존율을 측정하였다.The samples of Examples and Comparative Examples were suspended in purified water at concentrations of 50, 100, 200, and 400 μg/mL, respectively, and then cell viability was measured.
세포 독성은 MTT{3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide} 시약을 이용하여 세포 생존율을 측정하는 모스만(Mosmann)의 방법을 변형하여 수행하였다.Cytotoxicity was performed by modifying Mosmann's method of measuring cell viability using the MTT {3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide} reagent.
섬유아세포(HDF)를 각각 96-웰 플레이트에 1×104 cells/well의 농도로 분주하여 37℃, 5% CO2에서 48시간 동안 배양하였다.Fibroblasts (HDF) were dispensed into each 96-well plate at a concentration of 1×10 4 cells/well and cultured at 37°C and 5% CO 2 for 48 hours.
배양 배지를 제거하고 시료를 농도별로 처리한 배지에 48시간 동안 배양한 후 배지를 제거하고 PBS(Phosphate buffered saline)로 반복 세척하였다.The culture medium was removed, and the samples were cultured in medium treated at each concentration for 48 hours, then the medium was removed and washed repeatedly with PBS (Phosphate buffered saline).
MTT를 5mg/mL로 PBS에 녹여 50 μL 첨가하고 37℃, 5%의 CO2에서 48시간 동안 배양하였다. MTT was dissolved at 5 mg/mL in PBS, 50 μL was added, and cultured at 37°C and 5% CO 2 for 48 hours.
DMSO(Dimethyl sulfoxide)를 한 웰(well) 당 100L 넣고, 10분 동안 교반한 후 540nm에서 흡광도를 측정하였다.100 L of DMSO (Dimethyl sulfoxide) was added per well, stirred for 10 minutes, and absorbance was measured at 540 nm.
측정 결과, 각 시료의 모든 농도에서 세포 독성은 확인되지 않았다. 상기 결과는 상기 시료가 인체에 무해할 뿐만 아니라 인체 안전성이 우수함을 시사한다.As a result of the measurement, no cytotoxicity was confirmed at any concentration of each sample. The results suggest that the sample is not only harmless to the human body but also has excellent human safety.
실험예 2 : 멜라닌 생성 억제 활성 평가Experimental Example 2: Evaluation of melanin production inhibition activity
실시예 및 비교예 시료의 멜라닌 생성 억제 효과를 평가하고자 멜라노사이트인 B16F10을 배양하였다.To evaluate the effect of the samples of Examples and Comparative Examples on inhibiting melanin production, B16F10, a melanocyte, was cultured.
멜라노사이트인 B16F10을 8 x 104 cells가 되도록 6-well plate의 각 well에 분주한 후, 5% CO2, 37℃ 조건의 세포배양기에서 18시간동안 배양하였다.B16F10, a melanocyte, was dispensed into each well of a 6-well plate to make 8 x 10 4 cells, and then cultured in a cell incubator at 5% CO 2 and 37°C for 18 hours.
18시간 후, B16F10 세포의 배지를 제거하고 실시예 및 비교예의 시료를 동일 농도로 처리하여 5% CO2, 37℃ 조건의 세포배양기에서 2일 동안 배양하였다.After 18 hours, the medium of B16F10 cells was removed, and the samples of Examples and Comparative Examples were treated with the same concentration and cultured in a cell incubator under 5% CO 2 and 37°C conditions for 2 days.
2일 후, scraper를 이용하여 플레이트로부터 세포를 회수하고 1분간 원심분리하여 pellet 형태의 세포를 수득하였다. After 2 days, cells were recovered from the plate using a scraper and centrifuged for 1 minute to obtain pellet-shaped cells.
수득된 세포에 1N NaOH를 넣고 95℃에서 10분 동안 반응시켜 멜라닌을 용해시켰다.1N NaOH was added to the obtained cells and reacted at 95°C for 10 minutes to dissolve melanin.
10분 후 microplate reader를 이용하여 475nm 파장으로 melanin 생성량을 측정하였고, BCA assay를 이용하여 595nm 파장으로 단백질 양을 측정하였다.After 10 minutes, the amount of melanin produced was measured at a wavelength of 475 nm using a microplate reader, and the amount of protein was measured at a wavelength of 595 nm using a BCA assay.
각 실험군은 “melanin 절대량 / protein 절대량”으로 수치화하고, 실험군과 대조군을 상대 정량하였다.Each experimental group was quantified as “absolute amount of melanin / absolute amount of protein”, and relative quantification was performed between the experimental group and the control group.
Melanogenesis inducer로는 α-MSH를 사용하였고, 양성 대조군으로 알부틴을 사용하였다.α-MSH was used as a melanogenesis inducer, and arbutin was used as a positive control.
표 3을 참조하면, 실시예 1의 시료는 비교예 1 내지 6 대비 멜라닌 억제 활성이 우수하였으며, 추가적인 시료를 동시에 적용한 실시예 2 내지 6의 경우 멜라닌 억제 활성이 더욱 증진되었다.Referring to Table 3, the sample of Example 1 had excellent melanin inhibitory activity compared to Comparative Examples 1 to 6, and in the case of Examples 2 to 6 to which additional samples were applied simultaneously, the melanin inhibitory activity was further improved.
특히, 루시놀 및 가막사리 추출물을 동시에 함유하지 않는 비교예 7 내지 9의 시료는 멜라닌 억제 활성이 상대적으로 미흡하였으므로, 상기 결과는 상기 루시놀 및 가막사리 추출물의 조합에 따른 시너지 효과를 시사한다.In particular, the samples of Comparative Examples 7 to 9, which did not contain both rucinol and Camantharis extract, had relatively poor melanin inhibitory activity, so the results suggest a synergistic effect due to the combination of the rucinol and Camantharis extract.
실험예 3 : 타이로시네이즈(tyrosinase) 억제 활성 평가Experimental Example 3: Evaluation of tyrosinase inhibitory activity
실시예 및 비교예 시료의 멜라닌 생성 억제 효과를 평가하기 위해서, 멜라노사이트인 B16F10을 배양하였다.In order to evaluate the effect of the samples of Examples and Comparative Examples on inhibiting melanin production, B16F10, a melanocyte, was cultured.
멜라노사이트인 B16F10을 8 x 104 cells가 되도록 6-well plate의 각 well에 분주한 후, 5% CO2, 37℃ 조건의 세포배양기에서 18시간 동안 배양하였다.B16F10, a melanocyte, was dispensed into each well of a 6-well plate to make 8 x 10 4 cells, and then cultured in a cell incubator at 5% CO 2 and 37°C for 18 hours.
18시간 후, B16F10 세포의 배지를 제거하고 실시예 및 비교예의 시료를 동일 농도로 처리하여 5% CO2, 37℃ 조건의 세포배양기에서 2일 동안 배양하였다.After 18 hours, the medium of B16F10 cells was removed, and the samples of Examples and Comparative Examples were treated with the same concentration and cultured in a cell incubator under 5% CO 2 and 37°C conditions for 2 days.
2일 후, scraper를 이용하여 플레이트로부터 세포를 회수하고 1분간 원심분리하여 pellet 형태의 세포를 수득하였다. After 2 days, cells were recovered from the plate using a scraper and centrifuged for 1 minute to obtain pellet-shaped cells.
수득한 세포를 RIPA lysis buffer를 이용하여 용해시켰다.The obtained cells were lysed using RIPA lysis buffer.
96-well plate에 L-DOPA와 세포 용해액을 넣고 37℃에서 1시간동안 반응시켰다. 그 후, 450nm에서 흡광도를 측정하였다.L-DOPA and cell lysate were added to a 96-well plate and reacted at 37°C for 1 hour. Afterwards, the absorbance was measured at 450 nm.
표 4를 참조하면, 실시예 1의 시료는 비교예 1 내지 6 대비 피부 미백 활성이 우수하였으며, 추가적인 시료를 동시에 적용한 실시예 2 내지 6의 경우 피부 미백 효과가 더욱 증진되었다.Referring to Table 4, the sample of Example 1 had excellent skin whitening activity compared to Comparative Examples 1 to 6, and in the case of Examples 2 to 6 where additional samples were applied simultaneously, the skin whitening effect was further improved.
특히, 루시놀 및 가막사리 추출물을 동시에 함유하지 않는 비교예 7 내지 9의 시료는 피부 미백 효과가 상대적으로 미흡하였으므로, 상기 결과는 루시놀 및 가막사리 추출물의 조합에 따른 시너지 활성을 시사한다.In particular, the samples of Comparative Examples 7 to 9, which did not contain both rucinol and Camantharis extract, had relatively poor skin whitening effects, so the above results suggest synergistic activity due to the combination of rucinol and Gamagsari extract.
실험예 4 : 피부 밝기 개선 활성 평가Experimental Example 4: Evaluation of skin brightness improvement activity
실시예 및 비교예의 시료를 이용하여 피부에 적용한 후 피부 밝기 개선 효능을 확인하였다.The efficacy of improving skin brightness was confirmed after applying to the skin using the samples of Examples and Comparative Examples.
상기 실시예 및 비교예의 시료를 포함하는 에센스 제형의 화장료를 제조하고, 피험자 80명을 16개의 그룹으로 나누어 각각 적용한 후 피부의 밝기 변화를 확인하였다.Essence-type cosmetics containing the samples of the above examples and comparative examples were prepared, and 80 subjects were divided into 16 groups and applied to each group, and changes in skin brightness were confirmed.
취짐 전 세안 후, 제형화된 화장료를 적용하였으며, 3주간 매일 사용하였다. 피부밝기는 LAB 측정 장비(Konica Minolta CR-300 Chroma Meter) 로 확인하였다. After washing the face before taking a bath, the formulated cosmetic was applied and used daily for 3 weeks. Skin brightness was confirmed using LAB measurement equipment (Konica Minolta CR-300 Chroma Meter).
그 다음 상기 각 시험물질의 도포 후 측정시점과 도포 개시시점에서의 피부색의 차이(L*)를 하기 수학식 1에 따라 계산하였고, 결과를 하기 표 5에 나타내었다.Next, the difference (L*) in skin color between the measurement time after application of each test substance and the application start time was calculated according to Equation 1 below, and the results are shown in Table 5 below.
대조군은 실시예 및 비교예의 시료를 제외하고 제형화하였으며, 양성 대조군은 알부틴을 첨가하였다.The control group was formulated excluding the samples of Examples and Comparative Examples, and arbutin was added to the positive control group.
미백 효과는 시료 도포 부위와 대조군 부위의 L*의 비교로 판정하는데, L* 값이 2 정도일 경우는 침착된 색소의 미백화가 뚜렷한 경우이고, 약 1.5 이상이면 미백 효과가 있다고 판정할 수 있다.The whitening effect is determined by comparing the L* of the sample application area and the control area. If the L* value is around 2, whitening of the deposited pigment is evident, and if it is about 1.5 or more, it can be judged to have a whitening effect.
[수학식 1][Equation 1]
ΔL = 도포 후, 측정 시점에서의 L 값 - 도포 개시시점에서의 L 값ΔL = L value at the time of measurement after application - L value at the start of application
표 5를 참조하면, 제조예의 시료를 피부에 직접 적용하였을 때, 피부 밝기가 3주 이후 현저히 개선되었으며, 실시예 1의 시료를 실시예 2 내지 4의 시료와 동시에 적용하였을 때 시너지 효과가 구현되었다.Referring to Table 5, when the sample of Preparation Example was applied directly to the skin, skin brightness was significantly improved after 3 weeks, and a synergistic effect was realized when the sample of Example 1 was applied simultaneously with the samples of Examples 2 to 4. .
실험예 5 : 자유라디칼 소거 활성 평가Experimental Example 5: Evaluation of free radical scavenging activity
실시예 및 비교예의 추출물을 정제수에 현탁하여 자유라디칼 소거 활성(free radical scavenging acticity)을 평가하였다.The extracts of Examples and Comparative Examples were suspended in purified water to evaluate free radical scavenging activity.
DPPH 측정법은 억제제(inhibitor)가 안정한 라디칼 DPPH(2,2-Diphenyl-1-picrylhydrazyl radical)를 소거하여 탈색되는 정도를 540nm에서 흡광도를 측정하는 방법이다.The DPPH measurement method is a method of measuring the absorbance at 540 nm to determine the extent to which an inhibitor is decolorized by scavenging the stable radical DPPH (2,2-Diphenyl-1-picrylhydrazyl radical).
대조군으로 비타민 C를 이용하였고, 실험의 정확도를 위하여 동일한 실험을 3회 반복하였으며, 결과는 하기 표 6과 같다.Vitamin C was used as a control, and the same experiment was repeated three times to ensure accuracy of the experiment, and the results are shown in Table 6 below.
SC50의 값이 낮을수록 DPPH 자유라디칼의 소거 활성이 높은 것을 의미한다.표 6을 참조하면, 실시예의 시료는 비교예 대비 항산화 효과가 현저히 우수하였다.The lower the value of SC 50 , the higher the scavenging activity of DPPH free radicals. Referring to Table 6, the samples of the Examples had significantly better antioxidant effect than the Comparative Examples.
특히, 루시놀 및 가막사리 추출물을 동시에 포함하는 실시예 1은 일부가 결여된 비교예 7 내지 9에 비해 자유라디칼 소거 활성이 현저히 우수하였으며, 상기 결과는 상기 루시놀 및 가막사리 추출물의 조합에 따른 시너지 효과를 시사한다.In particular, Example 1, which simultaneously contains rucinol and acacia extract, was significantly superior in free radical scavenging activity compared to Comparative Examples 7 to 9, which lacked some of the extracts, and the results showed a synergistic effect due to the combination of rucinol and acacia extract. suggests.
실험예 6 : 자외선 조사에 따른 세포 보호 효과 시험Experimental Example 6: Test of cell protection effect according to ultraviolet irradiation
실시예의 시료의 UVB에 대한 세포 보호 효과를 측정하였다.The cytoprotective effect of the samples of the examples against UVB was measured.
1.0 x 104 cells/mL 농도의 섬유아세포를 96-웰 플레이트에 1 × 104 cells/well의 농도로 분주하여 37℃, 5% CO2 에서 48시간 동안 배양하였다.Fibroblasts at a concentration of 1.0
배양 배지를 제거하고 PBS로 2회 세척하여 잔존하는 배지를 제거하였다. 실시예의 시료를 농도별로 조정한 PBS로 교체하고 UVB(30mJ/cm2)를 5분간 조사하였다.The culture medium was removed and washed twice with PBS to remove any remaining medium. The samples of the examples were replaced with PBS adjusted according to concentration and irradiated with UVB (30mJ/cm 2 ) for 5 minutes.
PBS를 제거하고 잔존하는 시료를 제거한 후 24시간 더 배양하였다.After removing the PBS and removing the remaining sample, the culture was continued for another 24 hours.
MTT를 5 mg/mL로 PBS에 녹여 50L 첨가하고 37℃, 5%의 CO2에서 4 시간 동안 배양하였다.MTT was dissolved in PBS at 5 mg/mL, 50L was added, and cultured at 37°C and 5% CO 2 for 4 hours.
각 웰당 100 μL의 디메틸 설폭사이드용액을 가하여 염색된 세포를 용해시킨 후 마이크로 플레이트 리더로 570nm에서 흡광도를 측정하였다(표 7).100 μL of dimethyl sulfoxide solution was added to each well to lyse the stained cells, and then the absorbance was measured at 570 nm using a microplate reader (Table 7).
표 7을 참조하면, 루시놀 및 가막사리 추출물을 동시에 포함하는 실시예의 시료는 일부가 결여된 비교예 7 내지 9에 비해 자외선에 의해 손상된 세포를 효과적으로 회복시켰으며, 상기 결과는 각 구성의 조합에 따른 시너지 효과를 시사한다.Referring to Table 7, the sample of the example containing both rucinol and the extract of Violet fern effectively recovered cells damaged by ultraviolet rays compared to Comparative Examples 7 to 9, which lacked some of the components. The results show that the This suggests a synergistic effect.
실험예 7 : 피부 주름 개선 활성 평가Experimental Example 7: Evaluation of skin wrinkle improvement activity
피부 주름 개선 효과를 평가하기 위하여 하기와 같이 실험을 하였다.To evaluate the effect of improving skin wrinkles, an experiment was conducted as follows.
30세 이상의 성인 여성 80명을 대상으로 5명씩 16개의 그룹으로 나누고, 피시험자는 4주 동안 매일 아침, 저녁 세안 후 실시예 및 비교예의 시료를 제형화한 화장료를 안면에 고르게 도포하여 충분히 흡수시켰다.80 adult women over 30 years of age were divided into 16 groups of 5 people each. After washing their face every morning and evening for 4 weeks, the test subjects applied cosmetics formulated with the samples of Examples and Comparative Examples evenly to the face and allowed to be fully absorbed. .
이 때, 실시예 및 비교예의 시료는 모두 동일한 성분으로 제형화하였다.At this time, the samples of Examples and Comparative Examples were all formulated with the same ingredients.
주름개선 평가를 위하여 ANTERA 3D(Miravex, Ireland)를 적용하였으며, 기기측정은 시험물질 사용 전과 2주 사용 후, 4주 사용 후의 시점에서 이루어졌다.ANTERA 3D (Miravex, Ireland) was applied to evaluate wrinkle improvement, and instrument measurements were made before using the test substance, after 2 weeks of use, and after 4 weeks of use.
동일한 시험담당자가 모든 피시험자의 왼쪽 눈꼬리부위를 측정하였고, 측정의 재현성을 위하여 시험 물질 사용 전에 측정한 이미지와 오버랩시켜 동일 부위를 측정하였다.The same tester measured the left eye corner of all test subjects, and for reproducibility of measurements, the same area was measured by overlapping with the image measured before using the test substance.
촬영된 이미지는 ANTERA 3D 전용 소프트웨어인 ANTERA pro software를 이용하여 매칭시킨 후 일치된 측정부위를 분석에 사용하였다.The captured images were matched using ANTERA pro software, a dedicated software for ANTERA 3D, and the matched measurement area was used for analysis.
측정값은 측정변수인 Indentation index를 이용하여 피부의 주름을 나타내는 Wrinkles small값을 분석하였다.The measurement value was analyzed by using the measurement variable, the Indentation index, to analyze the Wrinkles small value, which represents wrinkles on the skin.
실시예 및 비교예의 시료를 제형화한 화장료 사용에 따른 피시험자의 4주 후의 Wrinkles small값의 변화량을 나타내었다(표 8). 주름 개선 효과가 우수할수록 Wrinkles small 값의 변화량은 크다.The change in Wrinkles small value of the test subject after 4 weeks according to the use of cosmetics formulated with the samples of Examples and Comparative Examples is shown (Table 8). The better the wrinkle improvement effect, the greater the change in Wrinkles small value.
표 8을 참조하면, 루시놀 및 가막사리 추출물을 동시에 포함하는 실시예의 시료를 제형화한 화장료 조성물은 피부 주름 개선 효과가 현저히 우수하였으며, 특히 추가적인 시료를 동시에 적용한 실시예 2 내지 6의 피부 주름 개선 효과는 더욱 개선되었다.Referring to Table 8, the cosmetic composition formulated with the samples of Examples containing both rucinol and Gamagsari extract had a significantly excellent skin wrinkle improvement effect, especially the skin wrinkle improvement effect of Examples 2 to 6 in which additional samples were applied simultaneously. has been further improved.
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 예를 들어, 단일형으로 설명되어 있는 각 구성 요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성 요소들도 결합된 형태로 실시될 수 있다.The description of the present invention described above is for illustrative purposes, and those skilled in the art will understand that the present invention can be easily modified into other specific forms without changing the technical idea or essential features of the present invention. will be. Therefore, the embodiments described above should be understood in all respects as illustrative and not restrictive. For example, each component described as unitary may be implemented in a distributed manner, and similarly, components described as distributed may also be implemented in a combined form.
본 발명의 범위는 후술하는 특허청구범위에 의하여 나타내어지며, 특허청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present invention is indicated by the patent claims described below, and all changes or modified forms derived from the meaning and scope of the claims and their equivalent concepts should be construed as being included in the scope of the present invention.
Claims (8)
으아리 추출물을 더 포함하는 화장료 조성물.According to paragraph 1,
A cosmetic composition further comprising an extract of Euari.
메밀꽃 추출물을 더 포함하는 화장료 조성물.According to paragraph 2,
A cosmetic composition further comprising buckwheat flower extract.
백향과 추출물 및 질려자 추출물 중 하나 이상을 더 포함하는 화장료 조성물.According to paragraph 3,
A cosmetic composition further comprising one or more of Baekhyang acetate extract and Achyranthesia extract.
항산화 용도를 더 포함하는 화장료 조성물.According to any one of claims 1 to 4,
A cosmetic composition further comprising an antioxidant use.
주름 개선 또는 광노화 방지 용도를 더 포함하는 화장료 조성물.According to any one of claims 1 to 4,
A cosmetic composition further comprising a use for improving wrinkles or preventing photoaging.
유연화장수, 영양화장수, 수분크림, 영양크림, 마사지크림, 영양로션, 에센스, 앰플, 젤, 아이크림, 오일, 파운데이션, 클렌징크림, 클렌징폼, 클렌징워터, 마스크팩, 스프레이 및 파우더로 이루어진 군에서 선택된 하나 이상으로 제형화된, 화장료 조성물.According to any one of claims 1 to 4,
A group consisting of softening lotion, nourishing lotion, moisturizing cream, nourishing cream, massage cream, nourishing lotion, essence, ampoule, gel, eye cream, oil, foundation, cleansing cream, cleansing foam, cleansing water, mask pack, spray and powder. A cosmetic composition formulated with one or more selected substances.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220073862A KR20230173287A (en) | 2022-06-17 | 2022-06-17 | A cosmetic composition comprising rucinol and natural extracts for skin-whitening |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220073862A KR20230173287A (en) | 2022-06-17 | 2022-06-17 | A cosmetic composition comprising rucinol and natural extracts for skin-whitening |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230173287A true KR20230173287A (en) | 2023-12-27 |
Family
ID=89378260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220073862A KR20230173287A (en) | 2022-06-17 | 2022-06-17 | A cosmetic composition comprising rucinol and natural extracts for skin-whitening |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230173287A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102014842B1 (en) | 2018-06-29 | 2019-08-27 | (주)셀아이콘랩 | Cosmetic composition containing natural extract |
KR102336538B1 (en) | 2020-06-09 | 2021-12-08 | 주식회사 코사이언스 | Composition for skin whitening comprising natural complex extracts with the effect of skin whitening |
-
2022
- 2022-06-17 KR KR1020220073862A patent/KR20230173287A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102014842B1 (en) | 2018-06-29 | 2019-08-27 | (주)셀아이콘랩 | Cosmetic composition containing natural extract |
KR102336538B1 (en) | 2020-06-09 | 2021-12-08 | 주식회사 코사이언스 | Composition for skin whitening comprising natural complex extracts with the effect of skin whitening |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20150139688A (en) | The Extract Of The Citrus grandis Osbeck Having Skin Whitening Activity And Cosmetic Composition Containing The Same | |
KR101387308B1 (en) | Skin whitening composition by using of dendropanax morbifera ferment extract | |
KR101825704B1 (en) | A cosmetic composition comprising coffee silver skin extract | |
KR102063686B1 (en) | Skin external composition containing extract of soybean root | |
KR102373899B1 (en) | Multifunctional cosmetic composition containing complex natural extracts effective for skin wrinkle improvement, whitening, cell regeneration, and wound healing as an active ingredient | |
KR20220166356A (en) | Extract of Moringa peregrina seed cake, process for its preparation and its use in cosmetic or nutricosmetic compositions | |
KR20170076147A (en) | Composition for improving skin | |
KR20150094832A (en) | Cosmetic composition containing an extract of mocordica charantia fruit as an active compotnet and method for preparing the extract of mocordica charantia fruit therefor | |
KR100882744B1 (en) | Manufacturing method of cometic compositions containing extract of paeonia suffruticosa andrew | |
KR102056263B1 (en) | A cosmetic composition comprising extract of coffee silver skin and coffee grounds | |
KR101445642B1 (en) | Cosmetic composition comprising the extract of Lagerstroemia indica as active ingredient | |
KR101176526B1 (en) | Cosmetic Composition Comprising the extract of Spiraea prunifolia var.simpliciflora as Active Ingredient | |
KR102390656B1 (en) | A cosmetic composition comprising chlorella extract for skin-whitening | |
KR20090097550A (en) | Cosmetic composition containing schizandrin and extracts | |
KR101987425B1 (en) | A cosmetic composition comprising salix gracilistyla extract | |
KR20230173287A (en) | A cosmetic composition comprising rucinol and natural extracts for skin-whitening | |
KR101971257B1 (en) | A cosmetic composition comprising tenebrio molitor extract | |
KR20080098925A (en) | Cometic compositions containing extract of paeonia suffruticosa andrew | |
KR100678865B1 (en) | Cosmetic composition for skin whitening comprising ramulus mori extract and carnitine as active ingredient | |
KR101479244B1 (en) | Cosmetic composition comprising the extract of Lagerstroemia indica as active ingredient | |
KR101479245B1 (en) | Cosmetic composition comprising the extract of Lagerstroemia indica as active ingredient | |
KR102525091B1 (en) | A cosmetic compositon for pore-minimizing comprising natural complex extract as an active ingredient | |
KR102556457B1 (en) | A whitening composition derived from natural products containing a large amount of lipoic acid | |
KR102438911B1 (en) | Composition for whitening, wrinkle improvement and anti-pollution composition | |
KR20190137328A (en) | Skin external application composition for anti-aging containing Rhodotypos scandens extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |